EGF and cancer: Incubation of cancer cells with the free ligand EGF also reduced B-ASO binding (by competition) with the extracellular domain of EGFR, reaching boron cellular uptake levels of 14 and 8 μg B/g for A431 and U87 cell lines, respectively (Figure 4A).